Effect of APC and Epo on the Inflammatory Response During Sepsis
NCT00229034 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2017-08-25
Summary
An observational study to determine the effect of APC and Epo in reducing the systemic inflammatory response during severe sepsis.
Conditions
- Sepsis
- Systemic Inflammation
Sponsors & Collaborators
-
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
lead OTHER
Principal Investigators
-
Amit Badhwar, PhD · Scientist
-
Neil Parry, MD · Surgeon
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-09-30
- Primary Completion
- 2010-12-31
- Completion
- 2011-09-30
Countries
- Canada
Study Locations
More Related Trials
-
Sensitivity and Specificity of Leucocytes Profiling Versus Platelet Indices in Prediction of Clinical Outcome for Candidates With Sepsis. A Bi-centric Observational Clinical Trial
NCT06612307 ·Status: COMPLETED
-
Sepsis: From Syndrome to Personalized Care
NCT04203979 ·Status: RECRUITING
-
Procurement of Human Specimens for the Evaluation of Early Markers of Sepsis
NCT01746407 ·Status: COMPLETED
-
Activated Protein C and Microcirculation
NCT01806428 ·Status: COMPLETED
-
Safety, Pharmacokinetics and Pharmacodynamics of BMS-936559 in Severe Sepsis
NCT02576457 ·Status: TERMINATED ·Phase: PHASE1
-
Biomarkers for the Early Identification of Sepsis in the Emergency Department
NCT02707718 ·Status: COMPLETED
-
Following of Myeloid-derived Suppressor Cells (MDSC) in Severe Sepsis: What Relationship With Systemic Inflammatory Syndrome?
NCT02903082 ·Status: TERMINATED
-
Study of Procalcitonin (PCT)-Guided Antibiotic Use in Severe Sepsis Patients Without Obvious Infection
NCT01025180 ·Status: TERMINATED ·Phase: PHASE4
-
Utility of Presepsin in Distinguishing Between Sepsis and SIRS
NCT02052895 ·Status: COMPLETED
-
Comparative Study of the Protein C Pathway in Septic and Non Septic Patients With Organ Failure
NCT00361725 ·Status: TERMINATED
-
Preemptive Resuscitation for Eradication of Septic Shock
NCT01449721 ·Status: COMPLETED ·Phase: NA
-
Early PREdiction of Severe Sepsis I (ExPRES-Sepsis I) Study
NCT02188992 ·Status: COMPLETED
-
Evaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration (IMMUNOSEPSIS)
NCT02803346 ·Status: UNKNOWN
-
Identification of Markers of Poor Clinical Prognosis in Sepsis by Epigenetic Analysis
NCT06446947 ·Status: RECRUITING
-
Zinc and Inflammation in Sepsis
NCT01328509 ·Status: COMPLETED
-
Interest of the Balance of Pro-coagulating and Profibrinolytis Activities of the Microparticles (MP) in the Prognosis of Septic Shock
NCT02062970 ·Status: UNKNOWN ·Phase: NA
-
Outcome Predictors in Patients With Severe Sepsis and Optimized Central Venous Oxygen Saturation
NCT01362829 ·Status: COMPLETED
-
Endotoxin Activity Assay and Microcirculation in Severe Sepsis
NCT02452138 ·Status: UNKNOWN
-
Acute Phase Proteins as Early Markers in Sepsis
NCT00641355 ·Status: UNKNOWN
-
A Prospective Observational Study of Sepsis
NCT05309889 ·Status: UNKNOWN
-
Dissecting How Peripheral Lymphocytes Are Lost During Sepsis
NCT03289312 ·Status: UNKNOWN
-
GR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In Adults
NCT00089986 ·Status: COMPLETED ·Phase: PHASE2
-
C-reactive Protein Information and Blood Cultures for Emergency Department Patients With Sepsis
NCT03714841 ·Status: UNKNOWN ·Phase: NA
-
Expression Profiles of Integrin αDβ2 on Neutrophils in Sepsis
NCT04103281 ·Status: RECRUITING
-
The Effects of Eicosapentaenoic Acid (EPA), Gamma-Linolenic Acid (GLA) and Antioxidants in the Treatment of Sepsis
NCT00329680 ·Status: COMPLETED ·Phase: PHASE4